Molecular Partners AG
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$153.76M
-2.1
-1.81
$5.64M
134
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Recently from Cashu
Couldn't load Cashu news
Something went wrong. Try refreshing the page.